首页> 外文学位 >In vitro diffusion studies for the studies for the assessment and optimization of drug release from various ketoprofen dermatological formulations.
【24h】

In vitro diffusion studies for the studies for the assessment and optimization of drug release from various ketoprofen dermatological formulations.

机译:体外扩散研究,用于评估和优化各种酮洛芬皮肤病学制剂的药物释放。

获取原文
获取原文并翻译 | 示例

摘要

Ketoprofen is a potent Non-Steroidal Anti --Inflammatory agent, widely used for symptomatic treatment of inflammatory syndromes such as rheumatoid arthritis, osteoarthritis and acute gouty arthritis. Unfortunately due to its poor solubility and hydrophobic nature several clinical failures have been demonstrated.;Orally administered Ketoprofen has been associated with systemic adverse events and in particular gastrointestinal disorders. Topical application of Ketoprofen is locally effective and at the same time reduces the risk of systemic adverse events.;This study was conducted to screen vehicles and various dermatological formulations. To develop an optimum topical dosage form of Ketoprofen. Formulations were developed using gels and emulsions based systems with an optimal pH. In-Vitro drug release studies were carried out using cellulose membrane and human cadaver skin. The general rank order of drug release from these samples was observed to be HPMC Gel base > Anionic emulsion base > Non Ionic emulsion base. In addition, the effects of various penetration enhancers including Propylene Glycol, Diethylene Glycol mono ethyl ether at 5%, 10% and 15% levels and urea at 2.5%, 5% and 7.5% levels were evaluated. In most cases addition of addition of additives had a little or no effects n enhancing the drug release from the bases.;Furthermore, to assess the in-vitro drug release / permeation of the drug formulation exhibiting optimum drug release was evaluated using human cadaver skin as barrier. Here, as expected the drug release was significantly reduced compared to data observed with cellulose membrane. Though the amount of drug release from the barrier was less, the drug release pattern was similar.
机译:酮洛芬是一种有效的非甾体抗炎药,广泛用于对症候群如风湿性关节炎,骨关节炎和急性痛风性关节炎的对症治疗。不幸的是,由于其不良的溶解性和疏水性,已经证明了几种临床失败。口服酮洛芬与全身性不良事件特别是胃肠道疾病有关。局部应用酮洛芬局部有效,同时降低了全身性不良事件的风险。;本研究旨在筛选媒介物和各种皮肤病学制剂。开发酮洛芬的最佳局部剂型。使用具有最佳pH值的基于凝胶和乳液的系统开发配方。使用纤维素膜和人体尸体皮肤进行了体外药物释放研究。观察到从这些样品中释放药物的一般顺序是HPMC凝胶基质>阴离子乳液基质>非离子乳液基质。此外,评估了各种渗透促进剂的作用,包括丙二醇,5%,10%和15%含量的二乙二醇单乙醚和2.5%,5%和7.5%含量的尿素。在大多数情况下,添加添加剂对增加药物从基质中的释放几乎没有影响。此外,使用人体尸体皮肤评估了体外药物释放/表现出最佳药物释放的药物制剂的渗透性作为障碍。在这里,与纤维素膜观察到的数据相比,药物释放明显降低了。尽管从屏障释放的药物量较少,但药物释放模式相似。

著录项

  • 作者

    Kelkar, Rucha.;

  • 作者单位

    Long Island University, The Brooklyn Center.;

  • 授予单位 Long Island University, The Brooklyn Center.;
  • 学科 Health Sciences Pharmacy.
  • 学位 M.S.
  • 年度 2014
  • 页码 97 p.
  • 总页数 97
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号